Phase 1 safety and pharmacokinetics of the novel enzyme replacement therapy neoGAA in treatment-naive and alglucosidase alfa-treated late-onset Pompe disease patients
MOLECULAR GENETICS AND METABOLISM. Bd. 117. H. 2. 2016 S. S117-S118
Erscheinungsjahr: 2016
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Ladha, Shafeeq (Autor)
Laforet, Pascal (Autor)
Mengel, Eugen (Autor)
Pestronk, Alan (Autor)
Pouget, Jean (Autor)
Schoser, Benedikt (Autor)
Straub, Volker (Autor)
Trivedi, Jaya (Autor)
Van Damme, Philip (Autor)
Vissing, John (Autor)
Young, Peter (Autor)
Shafi, Raheel (Autor)
Culm-Merdek, Kerry (Autor)
Short, Gerard (Autor)
Pena, Loren (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
